Company Filing History:
Years Active: 2003
Title: Mathew Choon Eng Gwee: Innovator in Therapeutic Molecules Derived from Snake Venom
Introduction
Mathew Choon Eng Gwee is a prominent inventor based in Singapore, known for his innovative contributions to the field of therapeutic molecules. His work focuses on the development of peptide molecules derived from snake venom, which have significant implications for pain management.
Latest Patents
Mathew holds a patent for his invention titled "Therapeutic molecules derived from snake venom." This invention relates to peptide molecules and their derivatives, homologues, analogues, and mimetics that are capable of inducing or facilitating analgesia or partial analgesia. The invention also includes a method for administering these peptides to achieve pain relief. The amino acid sequences of these peptide molecules are based on the sequences of snake venom toxins, particularly α-neurotoxins. He has 1 patent to his name.
Career Highlights
Mathew is affiliated with the National University of Singapore, where he conducts research and develops innovative solutions in the field of therapeutic applications. His work has garnered attention for its potential to improve pain management strategies.
Collaborations
Mathew has collaborated with notable colleagues, including Ponnampalam Gopalakrishnakone and Xiao Chun Pu, who share his passion for advancing research in therapeutic innovations.
Conclusion
Mathew Choon Eng Gwee's contributions to the field of therapeutic molecules highlight the importance of innovative research in pain management. His work with snake venom-derived peptides represents a significant advancement in the quest for effective analgesic solutions.